We also analyzed the mutation status of GAS2, GAS2L1, GAS2L2, and GAS2L3 in the glioma samples of TCGA‐LGG/GBM or CGGA‐WEseq_286 project, respectively. This evidence concerns the gene GAS2 and central nervous system cancer.